Local view for "http://purl.org/linkedpolitics/eu/plenary/2002-07-03-Speech-3-092"
Predicate | Value (sorted: default) |
---|---|
rdf:type | |
dcterms:Date | |
dcterms:Is Part Of | |
dcterms:Language | |
lpv:document identification number |
"en.20020703.3.3-092"2
|
lpv:hasSubsequent | |
lpv:speaker | |
lpv:spokenAs | |
lpv:translated text |
".
It is uncertain whether genetic modifications in plants and animals will cause serious problems in future. Despite this, we should already take account of the possibility that life as a whole, as a result of cross-fertilisation, especially in plant life, will change as a consequence, and that diseases will emerge to which man and animal are not entirely immune. Instead of taking time to look into this properly, this Parliament decided two years ago to create scope for commercial applications. This means that some undertakings can make a profit in the short term using something which will at a later stage mainly generate costs.
Now that the first line of defence against the possible risks of genetic contamination has been removed, it is all the more important for the second line of defence to remain in place. Thanks to the labelling of genetically contaminated products, consumers are given the option of not buying them. This is preferable to placing ordinary natural products in an exemption situation by prescribing that they state that they have not been modified by genetic procedures. However, it is to be feared that as usual, many consumers, mainly those on a low income, will buy the cheapest products. For them, paying attention to possible negative effects is a luxury they cannot afford. Labelling, therefore, only solves a small part of the problem."@en1
|
Named graphs describing this resource:
The resource appears as object in 2 triples